Ping An's lending and wealth management spinoff, valued above $39bn two years ago, has selected the New York Stock Exchange for its flotation.

The Novo-backed CAH therapy developer has set the range for an offering set to net it between $60m and $80m in proceeds.

MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.

10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

The GV-backed health insurance provider has agreed to merge with a special purpose acquisition company in a deal that will value it at $3.7bn.

GV is in line for an exit as the cancer therapy developer set terms for an offering that will raise more than $185m if it floats at the top of its range.

Eli Lilly will exit the genetic sequencing system provider in a cash-and-share acquisition by 10x Genomics that followed $50m in funding.

Recruit has exited creative services marketplace 99designs in a purchase of undisclosed size by Vistaprint parent Cimpress.

Porsche Ventures has exited fleet management technology provider Fleetonomy through a purchase by Via, hot off $200m in series E funding.

The online employee and further education provider is set to list on TSE’s Mothers Market, allowing Freebit, Matching Service Japan, MyNavi and Will Group to exit.